Clinical Trial

Meloxicam Versus Ibuprofen for Pain Control After Third Molar Exodontia in Adult Patients

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated November 25, 2024 (before its estimated January 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Third molar extraction is a common dental procedure, offently related with pain and swelling. The purpose of this study is to evaluate if Meloxicam has a better effect relieving pain after the extraction than Ibuprofen, one of the most common pain relieving drugs administered after this procedure.
Trial Details
NCT Number NCT06704113
Lead Sponsor Universidad Austral de Chile
Conditions Dental Pain, Sensation Disorders
Enrollment 68 participants
Start Date 2024-12-15
Primary Completion 2025-01-15 (estimated)
Study Completion 2025-01-20 (estimated)
Updated on ClinicalTrials.gov 2024-11-25